Harvard Stem Cell Institute (HSCI) researchers have identified a compound that helps protect the cells destroyed by spinal muscular atrophy (SMA), the most frequent fatal genetic disease in children under 2 years of age. SMA is a neurodegenerative disease targeting motor neurons, the long nerve cells that relay messages from the brain to the muscles...